These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
|
|
|
For the
quarterly period ended May 31, 2021
|
|
Loop Industries, Inc.
|
|
(Exact
name of Registrant as specified in its charter)
|
|
Nevada
|
|
27-2094706
|
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common
Stock
|
LOOP
|
Nasdaq
Global Market
|
|
Large accelerated
filer
|
☐
|
Accelerated
filer
|
☐
|
|
Non-accelerated
filer
|
☐
|
Smaller reporting
company
|
☒
|
|
|
|
Emerging growth
company
|
☐
|
|
|
|
Page No.
|
|
|
||
|
|
|
|
|
4
|
||
|
4
|
||
|
15
|
||
|
16
|
||
|
|
|
|
|
|
|
|
|
17
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
19
|
||
|
|
|
|
|
|
20
|
|
|
Contents
|
|
Page(s)
|
|
|
|
|
|
|
F-2
|
|
|
|
|
|
|
|
F-3
|
|
|
|
|
|
|
|
F-4
|
|
|
|
|
|
|
|
F-5
|
|
|
|
|
|
|
|
F-6
|
|
|
As
at
|
|
|
|
May 31,
2021
|
February 28,
2021
|
|
|
|
|
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash
and cash equivalents
|
$
18,037,062
|
$
35,221,951
|
|
Sales
tax, tax credits and other receivables (Note 3)
|
1,551,702
|
1,763,835
|
|
Prepaid
expenses (Note 4)
|
1,978,390
|
609,782
|
|
Total current
assets
|
21,567,154
|
37,595,568
|
|
Investment
in joint venture
|
1,500,000
|
1,500,000
|
|
Property,
plant and equipment, net (Note 5)
|
8,569,606
|
3,513,051
|
|
Intangible assets,
net (Note 6)
|
881,223
|
794,894
|
|
Total
assets
|
$
32,517,983
|
$
43,403,513
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Accounts
payable and accrued liabilities (Note 8)
|
$
9,057,423
|
$
8,124,865
|
|
Current
portion of long-term debt (Note 10)
|
971,257
|
938,116
|
|
Total
current liabilities
|
10,028,680
|
9,062,981
|
|
Long-term
debt (Note 10)
|
1,614,971
|
1,516,008
|
|
Total
liabilities
|
11,643,651
|
10,578,989
|
|
|
|
|
|
Stockholders' Equity
|
|
|
|
Series
A Preferred stock par value $0.0001; 25,000,000 shares authorized;
one share issued and outstanding (Note 12)
|
-
|
-
|
|
Common stock par value $0.0001; 250,000,000 shares
au
thorized; 42,433,320 shares issued and outstanding
(February 28, 2021 – 42,413,691) (Note 12)
|
4,244
|
4,242
|
|
Additional
paid-in capital
|
113,663,032
|
113,662,677
|
|
Additional
paid-in capital – Warrants
|
8,826,165
|
8,826,165
|
|
Accumulated
deficit
|
(101,819,334
)
|
(89,661,970
)
|
|
Accumulated
other comprehensive loss
|
200,225
|
(6,590
)
|
|
Total
stockholders' equity
|
20,874,332
|
32,824,524
|
|
Total
liabilities and stockholders' equity
|
$
32,517,983
|
$
43,403,513
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended
|
|
|
|
May 31,
2021
|
May 31,
2020
|
|
Revenue
|
$
-
|
$
-
|
|
|
|
|
|
Expenses :
|
|
|
|
Research
and development (Note 13)
|
8,637,905
|
1,480,588
|
|
General
and administrative (Notes 14)
|
3,160,571
|
1,953,081
|
|
Depreciation
and amortization (Notes 5 and 6)
|
132,001
|
255,974
|
|
Interest and other
financial expenses
(Note
18)
|
30,588
|
126,776
|
|
Interest
income
|
(9,761
)
|
(40,346
)
|
|
Foreign
exchange loss (gain)
|
206,060
|
76,641
|
|
Total
expenses
|
12,157,364
|
3,852,714
|
|
|
|
|
|
Net
loss
|
(12,157,364
)
|
(3,852,714
)
|
|
|
|
|
|
Other
comprehensive loss -
|
|
|
|
Foreign
currency translation adjustment
|
206,815
|
(170,412
)
|
|
Comprehensive
loss
|
$
(11,950,549
)
|
$
(4,023,126
)
|
|
Loss
per share
|
|
|
|
Basic
and diluted
|
$
(0.29
)
|
$
(0.10
)
|
|
Weighted
average common shares outstanding
|
|
|
|
Basic
and diluted
|
42,433,107
|
39,916,838
|
|
|
Three
months ended May 31, 2020
|
||||||||
|
|
Common
stock
par
value $0.0001
|
Preferred
stock
par
value $0.0001
|
|
|
|
|
|
||
|
|
Number
of Shares
|
Amount
|
Number
of Shares
|
Amount
|
Additional
Paid-in Capital
|
Additional
Paid-in Capital - Warrants
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive (Loss)
|
Total
Stockholders' Equity
|
|
Balance,
February 29, 2020
|
39,910,774
|
$
3,992
|
1
|
$
-
|
$
82,379,413
|
$
9,785,799
|
$
(53,317,047
)
|
$
(388,449
)
|
$
38,463,708
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of
shares upon the vesting of restricted stock units (Note
15)
|
6,131
|
1
|
-
|
-
|
(1
)
|
-
|
-
|
-
|
-
|
|
Warrant issued
for services (Note 17)
|
-
|
-
|
-
|
-
|
-
|
84,442
|
-
|
-
|
84,442
|
|
Stock options
issued for services (Note 15)
|
-
|
-
|
-
|
-
|
556,895
|
-
|
-
|
-
|
556,895
|
|
Restricted
stock units issued for services (Note 15)
|
-
|
-
|
-
|
-
|
370,487
|
-
|
-
|
-
|
370,487
|
|
Foreign
currency translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(170,412
)
|
(170,412
)
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,852,714
)
|
-
|
(3,852,714
)
|
|
Balance, May
31, 2020
|
39,916,905
|
$
3,993
|
1
|
$
-
|
$
83,306,794
|
$
9,870,241
|
$
(57,169,761
)
|
$
(558,861
)
|
$
35,452,406
|
|
|
Three
months ended May 31, 2021
|
||||||||
|
|
Common
stock par value $0.0001
|
Preferred
stock par value $0.0001
|
|
|
|
|
|
||
|
|
Number
of Shares
|
Amount
|
Number
of Shares
|
Amount
|
Additional
Paid-in Capital
|
Additional
Paid-in Capital – Warrants
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive Income (Loss)
|
Total
Stockholders’ Equity
|
|
Balance,
February 28, 2021
|
42,413,691
|
$
4,242
|
1
|
$
-
|
$
113,662,677
|
$
8,826,165
|
$
(89,661,970
)
|
$
(6,590
)
|
$
32,824,524
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of
shares upon the vesting of restricted stock units (Note
15)
|
19,629
|
2
|
-
|
-
|
(2
)
|
-
|
-
|
-
|
-
|
|
Stock options
issued for services (Note 15)
|
-
|
-
|
-
|
-
|
549,318
|
-
|
-
|
-
|
549,318
|
|
Restricted
stock units issued (forfeited) for services (Note
15)
|
-
|
-
|
-
|
-
|
(548,961
)
|
-
|
-
|
-
|
(548,961
)
|
|
Foreign
currency translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
206,815
|
206,815
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(12,157,364
)
|
-
|
(12,157,364
)
|
|
Balance, May
31, 2021
|
42,433,320
|
$
4,244
|
1
|
$
-
|
$
113,663,032
|
$
8,826,165
|
$
(101,819,334
)
|
$
200,225
|
$
20,874,332
|
|
|
Three
Months Ended May 31,
|
|
|
|
2021
|
2020
|
|
Cash Flows from Operating Activities
|
|
|
|
Net
loss
|
$
(12,157,364
)
|
$
(3,852,714
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
Depreciation
and amortization (Notes 5 and 6)
|
132,001
|
256,090
|
|
Stock-based
compensation expense (Note 15)
|
15,357
|
1,011,824
|
|
Accretion
and accrued interest expenses (Note 18)
|
21,408
|
17,963
|
|
Loss
on revaluation of foreign exchange contracts (Note 18)
|
-
|
98,502
|
|
Changes
in operating assets and liabilities:
|
|
|
|
Sales
tax and tax credits receivable (Note 3)
|
287,116
|
76,410
|
|
Prepaid
expenses (Note 4)
|
(1,326,519
)
|
(1,865,216
)
|
|
Accounts
payable and accrued liabilities (Note 8)
|
622,443
|
(720,759
)
|
|
Net
cash used in operating activities
|
(12,405,558
)
|
(4,977,900
)
|
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
Investment
in joint venture (Note 9)
|
-
|
(650,000
)
|
|
Additions
to property, plant and equipment (Note 5)
|
(4,867,007
)
|
(394,403
)
|
|
Additions
to intangible assets (Note 6)
|
(52,319
)
|
(144,386
)
|
|
Net
cash used in investing activities
|
(4,919,326
)
|
(1,188,789
)
|
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
Repayment
of long-term debt (Note 10)
|
(14,496
)
|
(12,693
)
|
|
Net
cash (used) provided by financing activities
|
(14,496
)
|
(12,693
)
|
|
|
|
|
|
Effect
of exchange rate changes
|
154,491
|
(29,534
)
|
|
Net
decrease in cash
|
(17,184,889
)
|
(6,208,916
)
|
|
Cash,
beginning of period
|
35,221,951
|
33,717,671
|
|
Cash,
end of period
|
$
18,037,062
|
$
27,508,755
|
|
|
|
|
|
Supplemental Disclosure of Cash Flow Information:
|
|
|
|
Income
tax paid
|
$
-
|
$
-
|
|
Interest
paid
|
$
9,178
|
$
10,311
|
|
Interest
received
|
$
9,761
|
$
40,346
|
|
|
May 31,
2021
|
February 28,
2021
|
|
Sales
tax
|
$
935,883
|
$
1,155,504
|
|
Research and
development tax credits
|
500,345
|
435,467
|
|
Other
receivables
|
115,474
|
172,864
|
|
|
$
1,551,702
|
$
1,763,835
|
|
|
May 31,
2021
|
February 28,
2021
|
|
Directors and
officers insurance
|
$
812,455
|
$
-
|
|
Deposits on
machinery and equipment
|
965,670
|
379,395
|
|
Other
|
200,265
|
230,387
|
|
|
$
1,978,390
|
$
609,782
|
|
|
As at May 31,
2021
|
||
|
|
Cost
|
Accumulated
depreciation, write-down and impairment
|
Net book
value
|
|
Building
|
$
2,053,585
|
$
(228,932
)
|
$
1,824,653
|
|
Land
|
5,173,641
|
-
|
5,173,641
|
|
Building
Improvements
|
1,938,596
|
(594,078
)
|
1,344,518
|
|
Machinery and
equipment
|
6,514,252
|
(6,514,252
)
|
-
|
|
Office equipment
and furniture
|
342,258
|
(115,464
)
|
226,794
|
|
|
$
16,022,332
|
$
(7,452,726
)
|
$
8,569,606
|
|
|
As at February 28,
2021
|
||
|
|
Cost
|
Accumulated
depreciation, write-down and impairment
|
Net book
value
|
|
Building
|
$
1,954,345
|
$
(201,589
)
|
$
1,752,756
|
|
Land
|
241,578
|
-
|
241,578
|
|
Building
Improvements
|
1,804,872
|
(474,114
)
|
1,330,758
|
|
Machinery and
equipment
|
6,514,252
|
(6,514,252
)
|
-
|
|
Office equipment
and furniture
|
292,946
|
(104,987
)
|
187,959
|
|
|
$
10,807,993
|
$
(7,294,942
)
|
$
3,513,051
|
|
|
As at May
31,
2021
|
As at February 28,
2021
|
|
|
|
|
|
|
|
|
|
Patents, at cost -
beginning of period
|
$
859,048
|
$
225,174
|
|
Patents,
accumulated depreciation – beginning of period
|
(64,154
)
|
(22,310
)
|
|
Patents, net
– beginning of period
|
794,894
|
202,864
|
|
|
|
|
|
Additions in the
period – patents
|
52,319
|
623,811
|
|
Amortization of
patents
|
(16,944
)
|
(41,844
)
|
|
Foreign exchange
effect
|
50,954
|
10,063
|
|
Patents, net
– end of period
|
$
881,223
|
$
794,894
|
|
|
Fair Value
Measurements as at May 31, 2021
|
||
|
|
Carrying Amount
|
Fair Value
|
Level in the
hierarchy
|
|
Instruments
measured at amortized cost:
|
|
|
|
|
Long-term
debt
|
$
2,586,227
|
$
2,596,787
|
Level
2
|
|
|
Fair Value
Measurements at February 28, 2021
|
||
|
|
Carrying Amount
|
Fair Value
|
Level in the
hierarchy
|
|
Instruments
measured at amortized cost:
|
|
|
|
|
Long-term
debt
|
$
2,454,123
|
$
2,464,540
|
Level
2
|
|
|
May 31,
2021
|
February 28,
2021
|
|
Trade accounts
payable
|
$
5,279,857
|
$
5,082,736
|
|
Accrued employee
compensation
|
1,051,109
|
970,154
|
|
Accrued
professional fees
|
1,040,791
|
1,270,628
|
| Accrued engineering fees |
862,645
|
535,359
|
|
Other accrued
liabilities
|
823,021
|
265,988
|
|
|
$
9,057,423
|
$
8,124,865
|
|
|
May 31,
2021
|
February 28,
2021
|
|
Investissement
Québec financing facility :
|
|
|
|
Principal
amount
|
$
1,830,048
|
$
1,741,612
|
|
Unamortized
discount
|
(271,001
)
|
(268,192
)
|
|
Accrued
interest
|
55,924
|
42,588
|
|
Total
Investissement Québec financing facility
|
1,614,971
|
1,516,008
|
|
Term
loan
|
|
|
|
Principal
amount
|
971,256
|
938,116
|
|
Less: current
portion
|
(971,256
)
|
(938,116
)
|
|
Total term loan,
net of current portion
|
-
|
-
|
|
Long-term debt, net
of current portion
|
$
1,614,971
|
$
1,516,008
|
|
Years
ending
|
Amount
|
|
February 28,
2022
|
$
45,560
|
|
February 28,
2023
|
57,985
|
|
February 29,
2024
|
319,417
|
|
February 28,
2025
|
319,417
|
|
February 28,
2026
|
319,417
|
|
Thereafter
|
1,727,084
|
|
Total
|
$
2,788,880
|
|
For
the period ended May 31, 2021
|
Number of
shares
|
Amount
|
|
Balance, February
28, 2021
|
42,413,691
|
$
4,242
|
|
Issuance of shares
upon settlement of restricted stock units
|
19,629
|
2
|
|
Balance, May 31,
2021
|
42,433,320
|
$
4,244
|
|
For
the period ended May 31, 2020
|
Number of
shares
|
Amount
|
|
Balance, February
29, 2020
|
39,910,774
|
$
3,992
|
|
Issuance of shares
upon settlement of restricted stock units
|
6,131
|
1
|
|
Balance, May 31,
2020
|
39,916,905
|
$
3,993
|
|
|
May 31,
2021
|
May 31, 2020
|
|
External
engineering
|
$
2,903,448
|
$
74,932
|
|
Employee
compensation
|
2,086,128
|
819,048
|
|
Machinery and
equipment expenditures
|
2,622,892
|
-
|
|
Demonstration plant
operating expenses
|
691,537
|
286,103
|
|
Other
|
333,900
|
300,505
|
|
|
$
8,637,905
|
$
1,480,588
|
|
|
May 31,
2021
|
May 31, 2020
|
|
Professional
fees
|
$
1,631,451
|
$
221,697
|
|
Employee
compensation
(1)
|
461,405
|
1,142,851
|
|
Directors and
officers insurance
|
868,647
|
473,574
|
|
Other
|
199,068
|
114,959
|
|
|
$
3,160,571
|
$
1,953,081
|
|
(1)
|
Includes
stock-based compensation expense. In the three-month period
ended May 31, 2021, the Company recorded RSU forfeitures for an
amount of $935,837 (2020 – $4,005) as a net reversal of
stock-based compensation.
|
|
|
2021
|
2020
|
|
|
Number of
units
|
Number of units
|
|
Outstanding,
beginning of period
|
1,083,412
|
1,300,518
|
|
Automatic share
reserve increase
|
-
|
-
|
|
Units
granted
|
(253,758
)
|
(87,114
)
|
|
Units
forfeited
|
295,524
|
2,989
|
|
Units
expired
|
-
|
-
|
|
Outstanding, end of
period
|
1,125,178
|
1,216,393
|
|
|
2021
|
2020
|
|
Interest on
long-term debt
|
$
20,059
|
$
19,727
|
|
Accretion
expense
|
10,529
|
8,547
|
|
Loss on
revaluation of foreign exchange contracts
|
-
|
98,502
|
|
|
$
30,588
|
$
126,776
|
|
|
Three months ended
May 31,
|
||
|
|
2021
|
2020
|
Change
|
|
Revenues
|
$
-
|
$
-
|
$
-
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
Research and
development
|
|
|
|
|
Stock-based
compensation
|
395,545
|
352,007
|
43,538
|
|
External
engineering
|
2,903,448
|
74,932
|
2,828,516
|
|
Employee
compensation
|
1,690,583
|
467,041
|
1,223,542
|
|
Machinery and
equipment expenditures
|
2,622,892
|
-
|
2,622,892
|
|
Demonstration plant
operating expenses
|
691,537
|
286,103
|
405,434
|
|
Other
|
333,900
|
300,505
|
33,395
|
|
Total research and
development
|
8,637,905
|
1,480,588
|
7,157,317
|
|
|
|
|
|
|
General and
administrative
|
|
|
|
|
Stock-based
compensation
|
(383,630
)
|
659,817
|
(1,043,447
)
|
|
Professional
fees
|
1,631,451
|
221,697
|
1,409,754
|
|
Employee
compensation
|
845,035
|
483,034
|
362,001
|
|
Directors and
officers insurance
|
868,647
|
473,574
|
395,073
|
|
Other
|
199,068
|
114,959
|
84,109
|
|
Total general and
administrative
|
3,160,571
|
1,953,081
|
1,207,490
|
|
|
|
|
|
|
Depreciation and
amortization
|
132,001
|
255,974
|
(123,973
)
|
|
Interest and other
financial expenses
|
30,588
|
126,776
|
(96,188
)
|
|
Interest
income
|
(9,761
)
|
(40,346
)
|
30,585
|
|
Foreign exchange
loss
|
206,060
|
76,641
|
129,419
|
|
Total
expenses
|
12,157,364
|
3,852,714
|
8,304,650
|
|
Net
loss
|
$
(12,157,364
)
|
$
(3,852,714
)
|
$
(8,304,650
)
|
|
|
Three Months Ended
May 31,
|
|
|
|
2021
|
2020
|
|
Net cash used in
operating activities
|
$
(12,405,558
)
|
$
(4,977,900
)
|
|
Net cash used in
investing activities
|
(4,919,326
)
|
(1,188,789
)
|
|
Net cash used by
financing activities
|
(14,496
)
|
(12,693
)
|
|
Effect of exchange
rate changes on cash
|
154,491
|
(29,534
)
|
|
Net (decrease)
increase in cash
|
$
(17,184,889
)
|
$
(6,208,916
)
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||
|
Number
|
|
Description
|
|
Form
|
|
File No.
|
|
Filing Date
|
|
Exhibit No.
|
|
|
Articles
of Incorporation, as amended to date
|
|
10-K
|
|
000-54768
|
|
May
30, 2017
|
|
3.1
|
|
|
|
By-laws,
as amended to date
|
|
8-K
|
|
000-54768
|
|
April
10, 2018
|
|
3.1
|
|
|
10.1
|
|
Amendment to Joint Venture
Agreements
dated June 18, 2021 by and between the Company,
Indorama Ventures Holdings LP and other parties
thereto
|
|
|
|
Filed herewith
|
|
|
|
|
|
10.2
|
|
Securities Purchase Agreement dated June 22, 2021 by and between SK
Global Chemical Co. LTD.
|
|
|
|
Filed
herewith
|
|
|
|
|
|
24.1
|
|
Power
of Attorney (contained on signature page to the previously filed
Annual Report on Form 10-K)
|
|
10-K
|
|
000-54768
|
|
08-May-19
|
|
24.1
|
|
|
Certification
of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Filed herewith
|
|
|
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Filed herewith
|
|
|
|
|
|
|
|
Certification
of Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Furnished herewith
|
|
|
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Furnished herewith
|
|
|
|
|
|
|
101.INS
|
|
XBRL
Instance Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
|
|
Filed herewith
|
|
|
|
|
|
Date:
July 15, 2021
|
By:
|
/s/ Daniel Solomita
|
|
|
|
Name:
|
Daniel
Solomita
|
|
|
|
Title:
|
President
and Chief Executive Officer, and Director (Principal Executive
Officer)
|
|
|
|
|
|
|
|
Date:
July 15, 2021
|
By:
|
/s/ Drew Hickey
|
|
|
|
Name:
|
Drew
Hickey
|
|
|
|
Title:
|
Chief
Financial Officer and Treasurer (Principal Accounting Officer and
Principal Financial Officer)
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|